These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25070347)

  • 1. Effects of exercise on central aortic pressure before and after treatment with renin-angiotensin system blockade in patients with hypertension.
    Lacy PS; Brunel P; Baschiera F; Botha J; Williams B
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1052-60. PubMed ID: 25070347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aliskiren- and ramipril-based treatment on central aortic blood pressure in elderly with systolic hypertension: a substudy of AGELESS.
    Baschiera F; Chang W; Brunel P;
    Vasc Health Risk Manag; 2014; 10():389-97. PubMed ID: 25061313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure and plasma renin activity responses to different strategies to inhibit the renin-angiotensin-aldosterone system during exercise.
    Williams B; Baschiera F; Lacy PS; Botha J; Prescott MF; Brunel P
    J Renin Angiotensin Aldosterone Syst; 2013 Mar; 14(1):56-66. PubMed ID: 22859712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of treatment withdrawal on brachial and central aortic pressure after direct renin inhibition or angiotensin receptor blockade.
    Lacy PS; Brunel P; Bader G; Jones A; Baschiera F; Düsing R; Williams B
    J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):614-22. PubMed ID: 25944854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin receptor blockade on central aortic systolic blood pressure in hypertensive Asians measured using radial tonometry: an open prospective cohort study.
    Teong HH; Chin AM; Sule AA; Tay JC
    Singapore Med J; 2016 Jul; 57(7):384-9. PubMed ID: 26875683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel description of the 24-hour circadian rhythms of brachial versus central aortic blood pressure and the impact of blood pressure treatment in a randomized controlled clinical trial: The Ambulatory Central Aortic Pressure (AmCAP) Study.
    Williams B; Lacy PS; Baschiera F; Brunel P; Düsing R
    Hypertension; 2013 Jun; 61(6):1168-76. PubMed ID: 23630950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
    Chrysant SG; Murray AV; Hoppe UC; Dattani D; Patel S; Hsu H; Zhang J
    Curr Med Res Opin; 2008 Apr; 24(4):1039-47. PubMed ID: 18307835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.
    Mahmud A; Feely J
    J Hum Hypertens; 2000 Sep; 14(9):541-6. PubMed ID: 10980584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
    Andersen K; Weinberger MH; Constance CM; Ali MA; Jin J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):157-67. PubMed ID: 19617271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin-ramipril study.
    Jekell A; Kalani M; Kahan T
    Heart Vessels; 2017 Jun; 32(6):674-684. PubMed ID: 27885499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study.
    Williams B; Cockcroft JR; Kario K; Zappe DH; Brunel PC; Wang Q; Guo W
    Hypertension; 2017 Mar; 69(3):411-420. PubMed ID: 28093466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.
    Moniwa N; Varagic J; Ahmad S; VonCannon JL; Simington SW; Wang H; Groban L; Brosnihan KB; Nagata S; Kato J; Kitamura K; Gomez RA; Lopez ML; Ferrario CM
    Hypertension; 2013 Feb; 61(2):417-24. PubMed ID: 23232645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparsion of central aortic pressure to brachial artery pressure in hypertensive patients on drug treatment: An observational study.
    Baba BA; Johan PT; Mohan JC
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S208-S212. PubMed ID: 30595260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients.
    Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H
    Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aliskiren: renin inhibitor for hypertension management.
    Cheng JW
    Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aliskiren and valsartan combination therapy for the management of hypertension.
    Epstein BJ
    Vasc Health Risk Manag; 2010 Sep; 6():711-22. PubMed ID: 20859542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Aortic Characteristic Impedance Explains Relations Between Urinary Na
    Mmopi KN; Norton GR; Bello H; Libhaber C; Masiu M; Da Silva Fernandes D; Sareli P; Peterson V; Woodiwiss AJ
    Hypertension; 2020 May; 75(5):1260-1270. PubMed ID: 32172617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.